AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
ERYTHROMYCIN STEARATE BP in Malawi
6 products registered with PMRA — 0 active, 6 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ERYTHROX 125MG/5ML POWDER FOR SUSPENSION POWDER FOR SUSPENSION | PMPB/PL12/42 | — | expired | 31 Mar 2025 |
| ERYKO 250MG TABLET TABLET | PMPB/PL89/8 | — | expired | 31 Mar 2024 |
| ASOMYCIN 250MG TABLET TABLET | PMPB/PL366/8 | — | expired | 30 Jun 2018 |
| ERILIDE-500 500MG TABLETS TABLETS | PMPB/PL421/7 | — | expired | 30 Jun 2014 |
| ERYMED-250 250MG TABLET TABLET | PMPB/PL292/17 | — | expired | 30 Jun 2010 |
| RYTHROCAPS 250MG CAPSULE CAPSULE | PMPB/PL7/97 | — | expired | 30 Jun 2006 |
ERYTHROMYCIN STEARATE BP — PMRA Registration Details
PMRA (Malawi) has 6 registered products containing ERYTHROMYCIN STEARATE BP, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track ERYTHROMYCIN STEARATE BP registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.